Molecular Imaging of a New Multimodal Microbubble for Adhesion Molecule Targeting

Area of Science:

• Biomedical Imaging
• Nanotechnology
• Immunology

Background:

• Inflammation is a key risk factor in many diseases, necessitating advanced diagnostic tools.
• Molecular imaging allows for the detection of specific molecules indicative of inflammation.
• Targeting adhesion molecules on activated endothelial cells and macrophages is a potential diagnostic strategy.

Purpose of the Study:

• To evaluate a novel multimodal microbubble (MB) contrast agent for targeting inflammation-activated endothelial cells and macrophages.
• To assess the diagnostic potential of polyvinyl alcohol-based MBs in ultrasound, magnetic resonance, and nuclear imaging.
• To investigate the specificity and efficiency of antibody-conjugated MBs against adhesion molecules.

Main Methods:

• Antibody-conjugated multimodal contrast agents (MBs) were developed.
• Binding efficiency was assessed using flow cytometry and confocal microscopy on inflamed murine/human endothelial cells and rat macrophages.
• In vivo targeting and distribution were visualized using SPECT imaging of 99mTc-labeled MBs in a rat peritonitis model.

Main Results:

• Targeted MBs showed significantly higher binding to adhesion molecules (ICAM-1, VCAM-1, E-selectin) on stimulated endothelial cells compared to non-targeted MBs (up to 6-fold for human, 12-fold for mouse).
• Under flow conditions, targeted MBs demonstrated enhanced adhesion to stimulated endothelial cells.
• SPECT imaging revealed a twofold increase in signal intensity in the abdomen of rats with peritonitis after administration of anti-ICAM-1 MBs.

Conclusions:

• The novel multilayer contrast agent specifically targets adhesion molecules upregulated by inflammatory stimuli in vitro.
• This agent demonstrates potential for disease-specific multimodal diagnostics in vivo.
• Further development could lead to advanced imaging techniques for inflammatory conditions.